DuPont today announced it has exercised its option to acquire full ownership of OxyMem Limited, a company that develops and produces Membrane Aerated Biofilm Reactor (MABR) technology for the treatment and purification of municipal and industrial wastewater.
“MABR is a new technology that offers unique and differentiated performance for secondary wastewater treatment over existing technologies,” said HP Nanda, global vice president and general manager, DuPont Water Solutions. “Wastewater is a fast-growing global market driven by industrial expansion, challenging water conditions and tightening regulations. Together with the MEMCOR MBR product DuPont is acquiring, this additional emerging technology provides more solutions for customers looking to reduce footprint and energy requirements for secondary wastewater treatment and enhances the performance of systems using other traditional water purification, reuse and recovery technologies.”
OxyMem has more than 60 employees and one production site located in Athlone, Ireland. The transaction will close before Dec. 31.
“OxyMem has benefited from working with DuPont, as an investor, for the last four years. A world-class water business, DuPont helped us refocus our development efforts to advance our Membrane Aerated Biofilm Reactor (MABR) technology,” said Wayne Byrne, CEO OxyMem Limited. “With the ownership of DuPont, we look forward to scaling MABR to meet the growing demand for the treatment and purification of municipal and industrial wastewater.”
OxyMem was founded in 2013, based on a technology spin-out from the University College Dublin, Ireland. The company is engaged in the development, manufacturing and sales of MABR units using patented technology for hollow fiber, silicone polydimethylsiloxane (PDMS) membranes to treat wastewater.
DuPont had owned 31 per cent of the company before taking full ownership.
Print this page
